NBIX icon

Neurocrine Biosciences

424 hedge funds and large institutions have $8.35B invested in Neurocrine Biosciences in 2022 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 161 increasing their positions, 143 reducing their positions, and 43 closing their positions.

Holders
424
Holders Change
+21
Holders Change %
+5.21%
% of All Funds
6.71%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
68
Increased
161
Reduced
143
Closed
43
Calls
$89.6M
Puts
$79.5M
Net Calls
+$10.1M
Net Calls Change
+$17.4M
Name Market Value Shares Shares
Change
Shares
Change %
TC
451
Truvestments Capital
Florida
-1,226 Closed
SFO
452
Standard Family Office
South Dakota
-525 Closed
JFGIW
453
Johnson Financial Group Inc (Wisconsin)
Wisconsin
-144 Closed
BAM
454
Byrne Asset Management
New Jersey
-98 Closed
CWS
455
Confluence Wealth Services
Pennsylvania
-56 Closed
MFAM
456
Motley Fool Asset Management
Virginia
-44 Closed
UB
457
UMB Bank
Missouri
-36 Closed
GI
458
Gradient Investments
Minnesota
-34 Closed
DHGWA
459
Dixon Hughes Goodman Wealth Advisors
North Carolina
$0 5 -19 -79%
HGWM
460
Harvest Group Wealth Management
Massachusetts
-12 Closed
MG
461
MilWealth Group
Wisconsin
-10 Closed
ACK
462
Andrew C. Karlinski
-7 Closed
CA
463
Cornerstone Advisory
Maryland
-5 Closed
LWA
464
Lenox Wealth Advisors
New York
-5 Closed
AWA
465
Aquire Wealth Advisors
Utah
-3 Closed
JGC
466
J. Goldman & Co
New York
CL
467
CSS LLC
Illinois
IC
468
Ikarian Capital
Texas
SM
469
SG3 Management
Puerto Rico
HNB
470
Huntington National Bank
Ohio
$0 1
SIC
471
SJS Investment Consulting
Ohio
$0 2 +2 New